EUVIMEDEUVIMED entdecken
Crossref

Cardenolide glycosides sensitize gefitinib-induced apoptosis in non-small cell lung cancer: inhibition of Na+/K+-ATPase serving as a switch-on mechanism

Chi-Min Du, Wohn-Jenn Leu, Yi-Huei Jiang, She-Hung Chan, Ih-Sheng Chen, Hsun-Shuo Chang, Lih-Ching Hsu, Jui-Ling Hsu, Jih-Hwa Guh

Naunyn-Schmiedeberg's Archives of Pharmacology · 2024

DOI: 10.1007/s00210-024-03031-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2024. Verfasst von Chi-Min Du und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, National Taiwan University, No. 33, Linsen S. Rd., Zhongzheng Dist, Taipei, 100, Taiwan. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Gefitinib, Apoptosis, Lung Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: National Science and Technology Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The treatment of non-small cell lung cancer (NSCLC) is known as a significant level of unmet medical need in spite of the progress in targeted therapy and personalized therapy. Overexpression of the Na+/K+-ATPase contributes to NSCLC progression, suggesting its potentiality in antineoplastic approaches. Epi-reevesioside F, purified from Reevesia formosana, showed potent anti-NSCLC activity through inhibiting the Na+/K+-ATPase, leading to internalization of α1- and α3-subunits in Na+/K+-ATPase and suppression of Akt-independent mTOR-p70S6K-4EBP1 axis. Epi-reevesioside F caused a synergistic amplification of apoptosis induced by gefitinib but not cisplatin, docetaxel, etoposide, paclitaxel, or vinorelbine in both NCI-H460 and A549 cells. The synergism was validated by enhanced activation of the caspase cascade. Bax cleavage, tBid formation, and downregulation of Bcl-xL and Bcl-2 contributed to the synergistic apoptosis induced by the combination treatment of epi-reevesioside F and gefitinib. The increase of membrane DR4 and DR5 levels, intracellular Ca2+ concentrations, and active m-calpain expression were responsible for the caspase-8 activation and Bax cleavage. The increased α-tubulin acetylation and activation of MAPK (i.e., p38 MAPK, Erk, and JNK) depending on cell types contributed to the synergistic mechanism under combination treatment. These signaling pathways that converged on profound c-Myc downregulation led to synergistic apoptosis in NSCLC. In conclusion, the data suggest that epi-reevesioside F inhibits the Na+/K+-ATPase and displays potent anti-NSCLC activity. Epi-reevesioside F sensitizes gefitinib-induced apoptosis through multiple pathways that converge on c-Myc downregulation. The data support the inhibition of Na+/K+-ATPase as a switch-on mechanism to sensitize gefitinib-induced anti-NSCLC activity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungGefitinibApoptosisLung NeoplasmsSodium-Potassium-Exchanging ATPaseCardenolidesHumansCell Line, TumorAntineoplastic AgentsDrug SynergismA549 Cells

Stichwörter der Autor:innen

Bax cleavageGefitinibNa+/K+-ATPaseNon-small cell lung cancerTubulin acetylation

Substanzen

GefitinibSodium-Potassium-Exchanging ATPaseCardenolidesAntineoplastic Agents

Autor:innen und Institutionen

  • School of Pharmacy, National Taiwan University, No. 33, Linsen S. Rd., Zhongzheng Dist, Taipei, 100, Taiwan.
  • Department of Cosmetic Science, Providence University, 200, Sec. 7, Taiwan Boulevard, Shalu Dist, Taichung, 43301, Taiwan.
  • School of Pharmacy, College of Pharmacy, Kaohsiung Medical University, Taiwan, Kaohsiung, Taiwan.
  • School of Pharmacy, National Taiwan University, No. 33, Linsen S. Rd., Zhongzheng Dist, Taipei, 100, Taiwan. jlhsu@mail.cgust.edu.tw.
  • Department of Nursing, Division of Basic Medical Sciences, Chang-Gung University of Science and Technology, Taoyuan, 333, Taiwan. jlhsu@mail.cgust.edu.tw.
  • Department of Medical Oncology, New Taipei Municipal TuCheng Hospital, New Taipei City, 236, Taiwan. jlhsu@mail.cgust.edu.tw.

Förderung

  • National Science and Technology Council

Zitieren

APA

Du, C. M., Leu, W. J., Jiang, Y. H., Chan, S. H., Chen, I. S., Chang, H. S., Hsu, L. C., Hsu, J. L., & Guh, J. H. (2024). Cardenolide glycosides sensitize gefitinib-induced apoptosis in non-small cell lung cancer: inhibition of Na+/K+-ATPase serving as a switch-on mechanism. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-024-03031-9

Vancouver

Du CM, Leu WJ, Jiang YH, Chan SH, Chen IS, Chang HS, et al. Cardenolide glycosides sensitize gefitinib-induced apoptosis in non-small cell lung cancer: inhibition of Na+/K+-ATPase serving as a switch-on mechanism. Naunyn-Schmiedeberg's Archives of Pharmacology. 2024. doi:10.1007/s00210-024-03031-9

BibTeX
@article{Du2024,
  author = {Du, Chi-Min and Leu, Wohn-Jenn and Jiang, Yi-Huei and Chan, She-Hung and Chen, Ih-Sheng and Chang, Hsun-Shuo and Hsu, Lih-Ching and Hsu, Jui-Ling and Guh, Jih-Hwa},
  title = {Cardenolide glycosides sensitize gefitinib-induced apoptosis in non-small cell lung cancer: inhibition of Na+/K+-ATPase serving as a switch-on mechanism},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2024},
  doi = {10.1007/s00210-024-03031-9}
}
Kostenlos starten →